PURIFIED pH NEUTRAL RHIZOCTONIA LACCASES AND NUCLEIC ACIDS ENCODING SAME

Abstract: The present invention relates to isolated nucleic acid fragments containing a sequence encoding a Rhizoctonia solani laccase having optimum activity at a neutral or basic pH, and the laccase proteins encoded thereby.

Description: PURIFIED PH NEUTRAL RHIZOCTONIA LACCASES AND NUCLEIC ACIDS ENCODING SAME Relate A lic tions This application is a continuation-in-part of co- pending U.S. Serial Nos. 08/122,230, 08/122,827, and 08/162,827, the contents of which are incorporated by reference in their entirety. Field of the Invention The present invention relates to isolated nucleic acid fragments encoding a fungal oxidoreductase enzyme and the purified enzymes produced thereby. More particularly, the invention relates to nucleic acid fragments encoding a phenol oxidase, specifically a laccase, which functions at a neutral pH. Background of the Invention Laccases (benzenediol:oxygen oxidoreductases) are multi-copper containing enzymes that catalyze the oxidation of phenolics. Laccase-mediated oxidations result in the production of aryloxy-radical intermediates from suitable phenolic substrate; the ultimate coupling of the intermediates so produced provides a combination of dimeric, oligomeric, and polymeric reaction products. Such reactions are important in nature in biosynthetic pathways which lead to the formation of melanin, alkaloids, toxins, lignins, and humic acids. Laccases are produced by a wide variety of fungi, including ascomycetes such as Aspergillus, Neurospora, and Podospora, the deuteromycete Botrytis, and basidiomycetes such as Collybia, Fomes, Lentinus, Pleurotus, Trametes, and perfect forms of Rhizoctonia . Laccase exhibits a wide range of substrate specificity, and each different fungal laccase usually differs only quantitatively from others in its ability to oxidize phenolic substrates. Because of the substrate diversity, laccases generally have found many potential industrial applications. Among these are lignin modification, paper strengthening, dye transfer inhibition in detergents, phenol polymerization, juice manufacture, phenol resin production, and waste water treatment. Although the catalytic capabilities are similar, laccases made by different fungal species do have different temperature and pH optima, and these may also differ depending on the specific substrate. A number of these fungal laccases have been isolated, and the genes for several of these have been cloned. For example, Choi et al . (Mol. Plant-Microbe Interactions : 119-128, 1992) describe the molecular characterization and cloning of the gene encoding the laccase of the chestnut blight fungus, Cryphonectria parasitica . Kojima et al . (J. Biol. Chem. 265: 15224-15230, 1990; JP 2-238885) provide a description of two allelic forms of the laccase of the white-rot basidiomycete Coriolus hirsutus . Germann and Lerch (Experientia 11: 801,1985; PNAS USA £1: 8854-8858, 1986) have reported the cloning and partial sequencing of the Neurospora crassa laccase gene. Saloheimo et al. (J. Gen. Microbiol. 137: 1537-1544, 1985; WO 92/01046) have disclosed a structural analysis of the laccase gene from the fungus Phlebia raάiata . However, virtually all of the known fungal laccases function best at acidic pHs (e.g., between pH 3..0 and 6.0), and are typically inactive at neutral or basic pHs. Since a number of the aforestated potential industrial methods are preferentially conducted at neutral or basic pH, most fungal laccases perform poorly in such methods. Thus, the available fungal laccases are inadequate for application in a number of important commercial methods. An exception to this rule is the extracellular laccase produced by certain species of Rhizoctonia . Bollag et al . have reported a laccase with a pH optimum of about 7.0 produced by Rhizoctonia praticola. A laccase of this type would be far more useful in industrial methods requiring neutral pH than previously known laccases. However, the R. praticola enzyme was neither purified nor further characterized, nor,to date, has any other laccase having this trait been purified or characterized. Moreover, although other laccase genes have been isolated, as described above, these have been genes encoding enzymes which function best at acidic pH. Recombinant production and commercially adequate yields of a pH neutral or basic laccase have thus been unattainable due to the fact that neither the enzyme per se nor the laccase gene encoding such an enzyme has previously been isolated and/or purified and sequenced. The present invention now provides a solution to each of these problems. Summary of the Invention The present invention relates to an isolated nucleic acid fragment comprising a nucleic acid sequence encoding a Rhizoctonia laccase which functions optimally at a pH between 6.0 to 8.5. By "functioning optimally" is meant that the enzyme exhibits significant(i.e. , at least about 30% of maximum, preferably at least about 50%, and most preferably from 50% to maximum) activity within the pH range of between about 6.0-8.5, as determined by activity in one or more standard laccase assays for substrates such as the syringaldazine, ABTS, 2,6-dimethoxyphenol, or 4 antiaminopyrine + N-ethyl-N-sulfobutyl-m-toluidine. A preferred substrate for the laccases of the present invention is syringaldazine. In a preferred embodiment, the laccase is a Rhizoctonia solani laccase. The invention also relates to a substantially pure laccase encoded by the novel nucleic acid sequence. By "substantially pure" is meant a laccase which is essentially (i.e.,≥90%) free of other non- laccase proteins. In order to facilitate production of the novel laccase, the invention also provides vectors and host cells comprising the claimed nucleic acid fragment, which vectors and host cells are useful in recombinant production of the laccase. The nucleic acid fragment is operably linked to transcription and translation signals capable of directing expression of the laccase protein in the host cell of choice. A preferred host cell is a fungal cell, most preferably of the genus Aspergillus . Recombinant production of the laccase of the invention is achieved by culturing a host cell transformed or transfected with the nucleic acid fragment of the invention, or progeny thereof, under conditions suitable for expression of the laccase protein, and recovering the laccase protein from the culture. The laccases of the present invention are useful in a number of industrial processes in which oxidation of phenolics is required. These processes include lignin manipulation, juice manufacture, phenol polymerization and phenol resin production. In a preferred embodiment, the enzyme of the invention is used in a process requiring a neutral or somewhat basic pH for greatest efficiency. Brief Description of the Figures Figure 1 illustrates the nucleotide and amino acid sequence of RSlacl. Lower case letters in the nucleotide sequence indicate the position of introns. Figure 2 illustrates the nucleotide and amino acid sequence of RSlac2. Lower case letters in the nucleotide sequence indicate the position of introns. Figure 3 illustrates a restriction map of the plasmid pMWR-1. Figure 4 illustrates the nucleotide and amino acid sequence of the translated region of RSlac3. Figure 5 illustrates the syringaldazine oxidase activity of RSlacl (90mM buffer, 20 μM syringaldazine, 20 * C) . Figure 6 illustrates the syringaldazine oxidase activity of RSlac2 (93mM buffer, 20 μM syringaldazine, 20 * C). Detailed Description of the Invention Certain species of the genus Rhizoctonia have been reported as producing laccase; therefore, an initial search focused on identifying the presence of these enzymes in various Rhizoctonia solani isolates. Samples are cultured and the supernatants periodically analyzed for the presence of laccase by the ABTS method, described below. Laccase is observed in all the Rhizoctonia cultures. Harvested laccases are electrophoretically separated and stained with ABTS. One isolate, RS22, produces a laccase with a basic pi, and is selected for further study. The remaining studies focus on purification and characterization of the enzyme from RS22. Briefly, the fermentation broth is filtered and concentrated by UF with a membrane cut off of about 10,000. A first ion exchange chromatography step is conducted at pH 4.5 in acetate buffer, with step elution using NaCl. The eluate is then ultrafiltered and rechromatographed, and eluted with a NaCl gradient. Active fractions are pooled for further study. The intact protein thus isolated and purified (hereinafter referred to as RSlac3) is first subjected to partial sequencing, and the N-terminal sequence obtained is as follows: AVRNYKFDIK VNVAPDGFQRPIVSV (SEQ. ID. NO.: 5) The protein is further subjected to digestion with a lysine- or glutamic-acid specific protease, and additional peptides obtained from the protein have the following sequences, which can be aligned with sequences in Coriolus hirsutus: Peptide 1: SQYVDGLRGPLVIYDPDDDH (SEQ. ID. NO: 6) Peptide 2: GLALVFAEAPSQIRQGVQSVQPDDA (SEQ. ID. NO.: 7) Peptide 3: SRYBVBBASTWMLEBWYHTPAXVLE (SEQ. ID. NO. 8) Peptide 4: SLGPTPNYVNPXIRDWRVGGTTW (SEQ. ID. NO. 9) The following peptides are also found, but do not correspond to Coriolus sequences Peptide 5: IRYVGGPAVX(N?)RSVI (SEQ. ID. NO.: 10) Peptide 6: ILANPA (SEQ. ID. NO.: 11) Peptide 7: YEAPSLPT (SEQ. ID. NO.: 12) In the above sequences, B designates a residue which is either aspartic acid or asparagine, and X designates unidentified residues. In order to initiate screening for a Rhizoctonia laccase gene, an R. solani genomic library is prepared. Total DNA is partially digested with restriction enzyme Sau3A, and electrophoresed in an agarose gel to isolate DNA fragments between 8 and 21 kb in size. The fractionated fragments are ligated to λ phage EMBL3 arms with BamHI ends, and the resulting phage packaged in vitro. These phage are used as a library to create a library of 170,000 plaques in E. coli and amplified 100-fold for future use. In order to develop probes for isolation of the R . solani laccase gene, the protein sequences of five known laccases are analyzed to determine consensus sequences, and two degenerate oligonucleotides constructed based on observed consensus sequences (Choi et al. supra; Germann and Lerch, supra; Saloheimo et al, supra, Kojima et al, supra) . These oligos are mixed with R. solani genomic DNA and a DNA fragment of 220 nucleotide fragment is amplified using a taq polymerase chain reaction(PCR) . The 220-nucleotide fragment is then cloned into plasmid vector. The PCR fragment is used as a probe to screen 25,000 plaques from the amplified genomic library. Positive clones from this screen fall into two classes that are subsequently shown, by DNA sequence analysis, to code for two different laccase genes, RSlacl and RSlac2. The nucleotide sequence for each of these genes (SEQ ID. NOS.: 1 and 3), and the predicted amino acid sequence for each protein (SEQ. ID. NOS.: 2 and 4), are presented in, respectively, Figures 1 and 2. The homology between the two sequences is approximately 63%. Compared to known laccase sequences from Coriolus hirsutus, Phlebia radiata, Aspergillus nidulans, Cryphonectria parasitica, and Neurospora crassa, the RS laccases show between about 30-40% homology. Each of the two coding sequences is cloned into an expression vector operably linked to Aspergillus oryzae taka-amylase transcription and translation signals (See Figure 3). Each of the two laccase expression vectors is transformed into an Aspergillus oryzae and Aspergillus niger host cell, and the host cells screened for the presence of laccase. For isolation of the . RSlac3 gene, polyA RNA is purified from R. solani mycelia grown in the presence of anisidine. The RNA is used as a template for cDNA synthesis. The cDNA is fractionated and fragments between 1.7-3.5 kb collected, and a cDNA library created by cloning the fractionated DNA into a yeast vector. 3000 transformants from this library- are screened on ABTS. After 24 hours, a single colony appears positive. The plasmid from the colony is isolated and the insert sequenced. Portions of the predicted amino acid sequence correspond with the sequences of the fragments obtained from RS 22, described supra . The complete nucleotide and amino acid sequences are depicted in Figure 4, and in SEQ. ID. NOS.: 13 and 14, respectively. RSlac.3 shows 48% homology with RSlacl and 50% homology with RSlac2. RSlac3 also shows 48% homology with the Coriolus hirsutus laccase gene. According to the invention, a Rhizoctonia gene encoding a pH neutral or basic laccase can be obtained by methods described above, or any alternative methods known in the art, using the information provided herein. The gene can be expressed, in active form, using an expression vector. A useful expression vector contains an element that permits stable integration of the vector into the host cell genome or autonomous replication of the vector in a host cell independent of the genome of the host cell, and preferably one or more phenotypic markers which permit easy selection of transformed host cells. The expression vector may also include control sequences encoding a promoter, ribosome binding site, translation initiation signal, and, optionally, a repressor gene or various activator genes. To permit the secretion of the expressed protein, nucleotides encoding a signal sequence may be inserted prior to the coding sequence of the gene. For expression under the direction of control sequences, a laccase gene to be treated according to the invention is operably linked to the control sequences in the proper reading frame. Promoter sequences that can be incorporated into plasmid vectors, and which can direct the transcription of the laccase gene, include but are not limited to the prokaryotic β-lactamase promoter (Villa-Kamaroff, et al., 1978, Proc. Natl. Acad. Sci. U.S.A. 7_5.:3727-3731) and the tac promoter (DeBoer, et al., 1983, Proc. Natl. Acad. Sci. U.S.A. £J221-25) . Further references can also be found in "Useful proteins from recombinant bacteria" in Scientific American, 1980, 242:74- 94; and in Sambrook et al., Molecular Cloning, 1989. The expression vector carrying the DNA construct of the invention may be any vector which may conveniently be subjected to recombinant DNA procedures, and the choice of vector will typically depend on the host cell into which it is to be introduced. Thus, the vector may be an autonomously replicating vector, i.e. a vector which exists as an extrachromosomal entity, the replication of which is independent of chromosomal replication, e.g. a plasmid, or an extrachro osomal element, minichromosome or an artificial chromosome. Alternatively, the vector may be one which, when introduced into a host cell, is integrated into the host cell genome and replicated together with the chromosome(s) into which it has been integrated. In the vector, the DNA sequence should be operably connected to a suitable promoter sequence. The promoter may be any DNA sequence which shows transcriptional activity in the host cell of choice and may be derived from genes encoding proteins either homologous or heterologous to the host cell. Examples of suitable promoters for directing the transcription of the DNA construct of the invention, especially in a bacterial host, are the promoter of the lac operon of E. coli , the Streptomyces coelicolor agarase gene dagA promoters, the promoters of the Bacillus licheniformis α-amylase gene (amyL) , the promoters of the Bacillus stearothermophilus maltogenic amylase gene (aiηyM) , the promoters of the Bacillus amyloliquefaciens α-amylase { amyQ) , or the promoters of the Bacillus subtilis xylA and xylB genes. In a yeast host, a useful promoter is the eno-1 promoter. For transcription in a fungal host, examples of useful promoters are those derived from the gene encoding A. oryzae TAKA amylase, Rhizomucor miehei aspartic proteinase, A . niger neutral α-amylase, A. niger acid stable α-amylase, A. niger or A . awxamsii glucoamylase (gluA) , Rhizomucor miehei lipase, A. oryzae alkaline protease, A. oryzae triose phosphate isomerase or A. nidulans acetamidase. Preferred are the T.AKA-amylase and gluA promoters. The expression vector of the invention may also comprise a suitable transcription terminator and, in eukaryotes, polyadenylation sequences operably connected to the DNA sequence encoding the laccase of the invention. Termination and polyadenylation sequences may suitably be derived from the same sources as the promoter.The vector may further comprise a DNA sequence enabling the vector to replicate in the host cell in question. Examples of such sequences are the origins of replication of plasmids pUC19, pACYCl77, pUBHO, pEl94, pAMBl and pIJ702. The vector may also comprise a selectable marker, e.g. a gene the product of which complements a defect in the host cell, such as the dal genes from B. subtilis or B. li - cheniformis , or one which confers antibiotic resistance such as ampicillin, kanamycin, chloramphenicol or tetracycline resistance. Examples of Aspergillus selection markers include amdS, pyrG, argB, niaD and sC, a marker giving rise to hygromycin resistance. Preferred for use in an Aspergillus host cell are the amdS and pyrG markers of A. nidulans or A. oryzae. A frequently used mammalian marker is the dihydrofolate reductase (DHFR) gene. Furthermore, selection may be accomplished by co-transformation, e.g. as described in WO 91/17243. It is generally preferred that the expression is extracellular. The laccases of the present invention may thus comprise a preregion permitting secretion of the expressed protein into the culture medium. If desirable, this preregion may be native to the laccase of the invention or substituted with a different preregion or signal sequence, conveniently accomplished by substitution of the DNA sequences encoding the respective preregions. For example, the preregion may be derived from a glucoamylase or an amylase gene from an Aspergillus species, an amylase gene from a Bacillus species, a lipase or proteinase gene from Rhizomucor miehei , the gene for the α-factor from Saccharomyces cerevisiae or the calf prochymosin gene. Particularly preferred, when the host is a fungal cell, is the preregion for A. oryzae TAKA amylase, A. niger neutral amylase, the maltogenic amylase form Bacillus NCIB 11837, B. stearothermophilus α-amylase, or Bacillus licheniformis subtilisin. An effective signal sequence is the A. oryzae TAKA amylase signal, the Rhizomucor miehei aspartic proteinase signal and the Rhizomucor miehei lipase signal. The procedures used to ligate the DNA construct of the invention, the promoter, terminator and other elements, respectively, and to insert them into suitable vectors containing the information necessary for replication, are well known to persons skilled in the art (cf., for instance, Sambrook et al. Molecular Cloning, 1989) . The cell of the invention either comprising a DNA construct or an expression vector of the invention as defined above is advantageously used as a host cell in the recombinant production of a enzyme of the invention. The cell may be transformed with the DNA construct of the invention, conveniently by integrating the DNA construct in the host chromosome. This integration is generally con¬ sidered to be an advantage as the DNA sequence is more likely to be stably maintained in the cell. Integration of the DNA constructs into the host chromosome may be performed according to conventional methods, e.g. by homologous or heterologous recombination. Alternatively, the cell may be transformed with an expression vector as described above in connection with the different types of host cells. The host cell may be selected from prokaryotic cells, such as bacterial cells. Examples of suitable bacteria are gram positive bacteria such as Bacillus subtilis, Bacillus licheniformis, Bacillus lentus, Bacillus brevis, Bacillus stearothermophilus, Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus coagulans, Bacillus circulans, Bacillus lautus, Bacillus megaterium, Bacillus thuringiensis , or Streptomyces lividans or Strep tomyces murinus, or gram negative bacteria such as E. coli . The transformation of the bacteria may for instance be effected by protoplast transformation or by using competent cells in a manner known per se. The host cell may also be a eukaryote, such as mammalian cells, insect cells, plant cells or preferably fungal cells, including yeast and filamentous fungi. For example, useful mammalian cells include CHO or COS cells. A yeast host cell may be selected from a species of Saccharomyces or Schizosaccharomyces, e.g. Saccharomyces cerevisiae. Useful filamentous fungi may selected from a species of Aspergillus, e.g. Aspergillus oryzae or Aspergillus niger. Alternatively, a strain of a Fusarium species, e.g. F. oxysporum, can be used as a host cell. Fungal cells may be transformed by a process involving proto¬ plast formation and transformation of the protoplasts fol- lowed by regeneration of the cell wall in a manner known per se. A suitable procedure for transformation of Aspergillus host cells is described in EP 238 023. A suitable method of transforming Fusarium species is described by Malardier et al., 1989. The present invention thus provides a method of producing a recombinant laccase of the invention, which method comprises cultivating a host cell as described above under conditions conducive to the production of the enzyme and recovering the enzyme from the cells and/or culture medium. The medium used to cultivate the cells may be any conventional medium suitable for growing the host cell in question and obtaining expression of the laccase of the invention. Suitable media are available from commercial suppliers or may be prepared according to published formulae (e.g. in catalogues of the .American Type Culture Collection) . The resulting enzyme may be recovered from the medium by conventional procedures including separating the cells from the medium by centrifugation or filtration, precipitat¬ ing the proteinaceous components of the supernatant or fil¬ trate by means of a salt, e.g. ammonium sulphate, followed by purification by a variety of chromatographic procedures, e.g. ion exchange chromatography, gel filtration chromatography, affinity chromatography, or the like. Preferably, the isolated protein is about 90% pure as determined by SDS-PAGE, purity being most important in food, juice or detergent applications. In a particularly preferred embodiment, the expression of laccase is achieved in a fungal host cell, such as Aspergillus. As described in detail in the following examples, the laccase gene is ligated into a plasmid containing the Aspergillus oryzae TAKA α-amylase promoter, and the Aspergillus nidulans amdS selectable marker. Alternatively, the amdS may be on a separate plasmid and used in co-transformation. The plasmid (or plasmids) is used to transform an Aspergillus species host cell, such as A. oryzae or A. niger in accordance with methods described in Yelton et al. (PNAS USA 81: 1470-1474,1984). Those skilled in the art will recognize that the invention is not limited to use of the nucleic acid fragments specifically disclosed herein, for example, in Figures 1 and 2. It will be apparent that the invention also encompasses those nucleotide sequences that encode the same amino acid sequences as depicted in Figures 1, 2 and 3, but which differ from those specifically depicted nucleotide sequences by virtue of the degeneracy of the genetic code. In addition, the invention also encompasses other nucleotide fragments,and the proteins encoded thereby, which encode laccase proteins having substantially the same pH optimum as those of Rhizoctonia solani , and which show a significant level of homology with the Rhizoctonia solani amino acid sequence. For example, the present data show that more than one species of Rhizoctonia produces a laccase with the desired pH profile; it is therefore expected that other Rhizoctonia species also produce similar laccases and therefore, using the technology described herein, can be used as a source for genes within the scope of the claimed invention. As also shown in the present examples, not only is there more than one nucleotide and amino acid sequence that encodes a laccase with the required characteristics, there is also considerable variation tolerated within the sequence while still producing a functional enzyme. Therefore, the invention also encompasses any variant nucleotide sequence, and the protein encoded thereby, which protein retains at least about an 80% homology with one or the other of the amino acid sequences depicted in Figures 1, 2 and 3, and retains both the laccase and pH optimum activity of the sequences described herein. In particular, variants which retain a high level(i.e., > 80%) of homology at highly conserved regions of the Rhizoctonia laccase are contemplated. Such regions are identified as residues 458- 469 in RSLAC1, and 478-489 in RSLAC2; and residues 131-144 in RSLACI and 132-145 in RSLAC2. Useful variants within the categories defined above include, for example, ones in which conservative amino acid substitutions have been made, which substitutions do not significantly affect the activity of the protein. By conservative substitution is meant that amino acids of the same class may be substituted by any other of that class. For example, the nonpolar aliphatic residues Ala, Val, Leu, and lie may be interchanged, as may be the basic residues Lys and Arg, or the acidic residues Asp and Glu. Similarly, Ser and Thr are conservative substitutions for each other, as are Asn and Gin. It will be apparent to the skilled artisan that such substitutions can be made outside the regions critical to the function of the molecule and still result in an active enzyme. Retention of the desired activity can readily be determined by conducting a standard ABTS oxidation method in 0.1M sodium phosphate at pH 7.0. The protein can be used in number of different industrial processes; although the enzyme is also functional to some extent at lower pH, the R. solani laccase is most beneficially used in processes that are usually conducted at a neutral or alkaline pH, since other laccases are not active in this pH range. These processes include polymerization of lignin, both Kraft and lignosulfates, in solution, in order to produce a lignin with a higher molecular weight. A neutral/alkaline laccase is a particular advantage in that Kraft lignin is more soluble at higher pHs. Such methods are described in, for example, Jin et al., Holzforschung 45(6) : 467-468, 1991; US Patent No. 4,432,921; EP 0 275 544; PCT/DK93/00217, 1992. The laccase of the present invention can also be used for in-situ depolymerization of lignin in Kraft pulp, thereby producing a pulp with lower lignin content. This use of laccase is an improvement over the current use of chlorine for depolymerization of lignin, which leads to the production of chlorinated aromatic compounds, which are an environmentally, undesirable by-product of paper mills. Such uses are described in, for example, Current opinion in Biotechnology 2.: 261-266, 1992; J. Biotechnol. 2_L: 333-339, 1992; Hiroi et al. , Svensk papperstidning 5_: 162-166, 1976. Since the environment in a paper mill is typically alkaline, the present laccase is more useful for this purpose than other known laccases, which function best under acidic conditions. Oxidation of dyes and other chromophoric compounds leads to decolorization of the compounds. Laccase can be used for this purpose, which can be particularly advantageous in a situation in which a dye transfer between fabrics is undesirable, e.g., in the textile industry and in the detergent industry. Methods for dye transfer inhibition and dye oxidation can be found in WO 92/01406, WO 92/18683, EP 0495836 and Calvo, Mededelingen van de Faculteit Landbouw-wetenschappen/Rijiksuniversitet Gent.56: 1565-1567, 1991. The present laccase can also be used for the polymerization of phenolic compounds present in liquids. An example of such utility is the treatment of juices, such as apple juice, so that the laccase will accelerate a precipitation of the phenolic compounds present in the juice, thereby producing a more stable juice. Such applications have been described in Stutz, Fruit processing 7/93. 248-252, 1993; Maier et al., Dt. Lebensmittel- rindsπhau 86(5) : 137-142, 1990; Dietrich et al., Fluss. Obst 57 (2) : 67-73, 1990. The invention is further illustrated by the following non-limiting examples. EXAMPLES 1.Purification and characterization of R. solani laccase Individual isolates of R. solani cultured on potato dextrose agar (Difco) are examined for laccase enzyme formation by transferring a small piece of agar containing vigorous growth to 100 ml CFM ( 24.0 g potato dextrose broth, 3.0 g yeast extract, 1.0 ml Microelement solution [0.80 g KH 2 P0 , 0.64 g CuS0 4 -5H 2 0, 0.11 g FeS0 -7H 2 0, 0.80 g MnCl 2 -4H 2 0, 0.15 g ZnS0 -7H 2 0, distilled water to 1000 ml], distilled water to 1000 ml) in a 500 ml shake flask. Incubation is at room temperature, at 200 rpm on an orbital shaker. Samples are harvested at 50, 74, 122 and 170 hours, centrifuged and the clear supernatant analyzed for laccase with its ABTS (ABTS= 2,2'-azinobis (3 ethylbenzothiazoline- 6-sulfonic acid) . The analysis is carried out by adding 200 μl of 2mM ABTS in 0.1 M phosphate buffer, pH 7, and observing the change in absorbance at 418 nm after 30 minutes incubation at room temperature (approximately 23-25' C) . This method is modified from a peroxidase analysis method described by Putter and Becker (Peroxidases, in: Bergmeyer, H.U.(ed.), Methods of Enzymatic Analysis, 3rd ed., Vol.Ill, pp.286-293, 1983) Each of the laccases harvested at 172 hours is electrophoretically separated and stained with ABTS as chromogen. Several distinct patterns emerge; the strain RS 22 is shown to produce a laccase having a basic pi, and is chosen for further characterization. Laccase activity is also deter inable by the syringaldazine method. Laccase catalyzes the oxidation of syringaldazine to tetramethoxy azo bis-methylene quinone under aerobic conditions, with a change of color from yellow to violet. 3000 μl of 25 mM acetate buffer (containing lOmg/1 cuprisulfate, 5 H 2 0) at pH 5.5, 30'C, is mixed in a 1 cm cuvette with 225 μl 0.28 mM syringaldazine (5mg solubilized in 25 ml ethanol and adjusted to 50 ml with demineralized water). The.mixture is then mixed with 100 μl of a laccase dilution (diluted in acetate buffer so that the increase in absorbance(ΔOD) is within the range of 0.1-0.6). The reaction mixture is placed in a 30"C thermostated spectrophotometer and the reaction is followed at 530 nm for 10 to 70 seconds from the addition of laccase. The activity of the enzyme is calculated as ΔOD/minute x 0.677 x dilution factor, and is expressed as LACU. For purification of the Rhizoctonia laccase, 2.1 liter of culture medium with a LACU activity of 0.19 LACU/ml is filtered through a 10 μm filter and concentrated to 230 ml by ultrafiltration using a Filtron Minisette OMEGA membrane with a cutoff value of 10 kDa. The pH of the sample is 5.3 and the activity of the concentrated sample is determined to be 3.34 LACU/ml. After pH adjustment to 4.5 and filtration due to slight precipitation, the sample is applied to a 40 ml S Sepharose Fast Flow column equilibrated with 20mM acetate buffer at pH 4.5 (buffer A) . The column is washed in buffer A and eluted with buffer A containing 1 M NaCl. Active fractions are collected and pooled. This active pool is concentrated and buffer exchanged to buffer A using an Amicon ultrafiltration unit equipped with a Diaflo YM10 membrane. This sample is rechromatographed on a 5 ml S Sepharose High Performance column using the method described above except that elution is carried out with a linear gradient over 30 column volumes from buffer A to buffer A containing 0.5 M NaCl. The fractions from this purification exhibiting highest activity are pooled. Approximately 45 mg laccase are obtained, when protein concentration is estimated by one absorption unit at A280 nm equal to lmg/ml. The protein is >90% pure as judged by SDS-PAGE. The molecular weight estimated by SDS-PAGE is approximately 67 kDa. The specific activity of the purified protein is 1 LACU/mg. The pH profile of the purified protein, using syringaldazine as substrate is show in Table 1, below. Table 1. EH 5 6. 7 % activity 0.5 31 100 59 For sequencing of the protein, peptides are generated using wither a lysine-specific protease from Achromobacter (Achromobacter protease I) or a glutamic acid specific protease from Bacillus licheni formes . The peptides are purified by reverse phase HPLC employing linear gradients of 80% 2-propanol containing 0.08% aqueous TFA (solvent B) in 0.1% aqueous TFA (solvent A). N-terminal amino acid sequence analysis of the intact protein and of purified peptides are carried out in an Applied Biosyste s 473A protein sequencer according to the manufacturer's instructions. Initial partial sequencing of the isolated protein yields the following N-terminal sequence: AVRNYKFDIKNVNVAPDGFQRPIVSV (SEQ. ID. NO.: 5) The protein is then digested with either a lysine- or glutamic-acid specific protease, and following additional peptides identified. Peptides 1-4 can be aligned with sequences in the laccase of Coriolus hirsutus: Peptide 1: SQYVDGLRGPLVIYDPDDDH (SEQ. ID. NO: 6) Peptide 2: GLALVFAEAPSQIRQGVQSVQPDDA (SEQ. ID. NO.: 7) Peptide 3: SRYBVBBASTWMLEBWYHTPAXVLE (SEQ. ID. NO. 8) Peptide 4: SLGPTPNYVNPXIRDWRVGGTTW (SEQ. ID. NO. 9) Peptide 5: IRYVGGPAV (N?)RSVI (SEQ. ID. NO. : 10) Peptide 6: ILANPA (SEQ. ID. NO.: 11) Peptide 7: YEAPSLPT (SEQ. ID. NO.: 12) An X in the above sequences designates an unidentified residue, and B represents a residue which is either aspartic acid or asparagine. 2.Isolation of R . solani laccase gene A study of the known amino acid sequences of fungal laccases obtained from non-Rhizoctonia species (Choi et al., supra; German et al., supra; Saloheimo et al. supra; and Kojima et al, supra) is conducted to determine the presence of consensus sequences among them. Two regions of high identity, IHWHGFFQ and TFWYHSH, are found near the amino terminal third of the protein. Based on these consensus sequences and the corresponding DNA sequences, three degenerate oligonucleotides, 0-lac2 [TGG/AAAGACCATA/GGTGTCG/AGTA/G] ,its complement 0-lac2r, and 0-lac3 [ATCCAT/CTGGCAT/CGGG/CA/TTCTTCCAG/A] , are synthesized using an Applied Biosystems 394 DNA/RNA synthesizer. The synthesized oligos are used in a polymerase chain reaction (PCR) to screen Rhizoctonia solani genomic DNA for a laccase gene or fragment thereof. For amplifications of genomic DNA, 0.5 μg of genomic DNA is incubated with lμM of each primer, 200μM of dNTPs, and 1 U taq polymerase (Boehringer Mannheim) in [10 mM Tris-Cl, 1.5 mM MgCl 2 , 50 mM KCl, 1 mg/ml gelatine;pH 8.3], The reactions are incubated for 1x5 minutes at 95 * C, 30x[l minute at 95'C, 1 minute at 50-60'C, 1 minute at 72 * C], and 1x5 minutes at 72 * C. The PCR reactions amplify a DNA fragment of 220 nucleotides. The PCR product is cloned, according to manufacturer's directions, into the TA cloning vector (InVitrogen Corp.). Characterization of the PCR product by DNA sequencing of individual clones distinguishes two separate laccase genes designated RSlacl and RSlac2. To prepare a R . solani genomic library, R. solani DNA is partially digested with restriction enzyme Sau3A, and electrophoresed through a 0.8% Sea Plaque Agarose (FMC Bioproducts) in a Tris/Acetate/EDTA buffer to isolate those DNA fragments between 8.0 an 21 kb in size. The gel fractionated fragments are further purified with Beta- Agarase(New England Biolabs) according to manufacturer's instruction, and then ligated to lambda phage EMBL3 arms with BamHl ends. The resulting phages are packaged in vitro using Gigapack II packaging extrac (Stratagene) . 25 ml of TB media+0.2% maltose and 10 MgS0 4 is inoculated into a 50 μl aliquot of an overnight culture of E. coli K802 (supE, hsdR, gal, metB) and incubated at 37 "C with shaking until the A600=0.5. 25 μl of a 1:10 and 1:50 dilution of the packaged phage are mixed with 250 μl of the K802 cells, and incubated for 20 minutes at 37 * C. To each dilution, 5 μl of melted top agar at 48 'C are added. The mix is then plated onto prewarmed LB plates and incubated at 37 * C for at least 12 hours. From these phage, a library of 170,000 plaques in E. coli K802 is created and amplified 100-fold for future use. To screen for the laccase gene, 25,000 plaques from the amplified genomic library are plated onto NZY/agarose plates for plaque lifts using conventional methods. Filters are screened using the 220 nucleotide PCR fragment randomly labelled to 5xl0 8 cpm/μg as a probe. Filters are hybridized in 50% formamide, 6xSSC for 16 hours at 42'C and washed with 0.5xSSC, 0.1% SDS at 65"C. Positive clones are picked and rescreened using conventional methods. The nine positive clones identified fell into two classes that by DNA sequence analysis are shown to code for two different laccase genes, RSlacl and RSlac2. The complete nucleotide sequence of each of these genes is determined using fluorescent nucleotides and an Applied Biosystems automatic DNA sequencer (Model 363A, version 1.2.0) . The nucleotide and predicted amino acid sequences are depicted in Figures 1 and 2. For isolation of RSlac3, poly A RNA purified from R . solani mycelia grown in the presence of 1 mM anisidine is used as a template for cDNA synthesis using standard protocols. The cDNA is fractionated by electrophoresis through a 0.8% agarose gel and DNA fragments between 1.7 and 3.5 kb in size are collected. A library is then created by cloning the size-fractionated cDNA into the yeast expression vector pYES2. 3000 yeast transformantε from this library- are plated initially on YNB (1.7 g yeast nitrogen base without amino acids, 5 g (NH 4 ) 2 S0 per liter) with 2% glucose. After 4 days growth at 30'C, the resulting colonies are replica plated to YNB with 0.1% glucose, 2% galactose and 2mM ABTS [2,2'-azino-bis(3- ethylbenzthiazoline-6-sulfonic acid; Sigma # A-1888) . After 24 hours of growth at 30"C a single colony has a light green halo which gradually turns a dark purple. The plasmid from this colony is isolated and the insert sequenced. The sequence of the translated portion of the RSlac3 gene and protein is shown in SEQ.ID NOS. 13 and 14, and in Figure 4. 3. Expression of laccase gene The plasmid pMWR-1 is a pUC derived vector containing the TAKA amylase transcription regulation signals and the TAKA amylase signal sequence. This plasmid is engineered with a unique Sfil site at the signal sequence cleavage site, and a 3' adjacent Nsil site such that these two restriction enzymes can be used to introduce, in frame, a foreign protein. Using a PCR reaction (conducted as described above, but with 100 ng of the appropriate linearized plasmid DNA as a template) and mutagenized primers, an Sfil site is introduced at amino acid 12 and amino acid 14 of RSlacl and RSlac2, respectively, such that the protein coding sequences are in frame with the TAKA signal sequence. In addition, a PCR amplification is also used to introduce a PstI site (CTGCAG) at the 3' end of RSlacl and an Nsil site (ATGCAT) at the 3' end of RS2ac2. To prepare for transformation, cells of Aspergillus oryzae are cultivated in YPG (lg/1 yeast extract, 0.25 g K 2 P0 4 . 0.125 g/MgS0 4 , 3.75 g glucose) at 34°C with 100-120rpm for 16-20 hours, then collected by filtration with miracloth. Cells are washed with Mg solution (0.6M MgS0 4 -7H 2 0), then 2-6 g of cells are taken up in 10 ml MgP(1.2M MgS0 4 -7H 2 0, lOmM NaH 2 P0 4 •2H 2 0;pH 5.8).To this is added 1 ml of Novozyme® 234 (120 mg/ml MgP) , and the sample kept on ice for 5 minutes. One ml of BSA (12 mg/ml) is added, and the sample shaken gently at 34-37'C. Protoplasts are collected by filtration through miracloth, and overlain with 5 ml of ST (0.6 M Sorbitol, lOOmM Tris; pH 7) . The sample is spun at 2500 rp for 15 minutes, and a band of protoplasts collected. Two volumes of STC (1.2M Sorbitol, 10 mM tris, 10 mM CaCl 2 -2H 2 0;pH 7.5) are added and the sample is spun at 2500 rpm for 5 minutes. The precipitate is washed twice with 5 ml of STC, and the protoplasts suspended in 0.5-lml of STC. For the transformation process, the protoplast concentration is adjusted to l-5xl0 7 /ml. To 100 μl of protoplast solution is added a maximum of 10 μl of DNA solution (5-10 μg of supercoiled DNA) and 0.2 ml of PEG (60% PEG4000, lOmM Tris, lOmM CaCl 2 -H 2 0; pH 7.5),and the combination is mixed well. The sample is kept at room temperature for 25 minutes; then to it is added first 0.2 ml PEG, with mixing, the 0.85 ml PEG with mixing. The mixture is kept at room temperature for 20 minutes, then spun at 4000 rpm for 15 minutes. The precipitate is washed with 2 ml of STC by spinning at 2500 rpm for 10 minutes. The protoplasts are resuspended in 0.2-0.5 ml of STC, and then spread on COVE plates. COVE medium (pH 7) contains 342.3 g/1 sucrose, 25 g/1 agar and a salt solution comprising 26 g/1 KCl, 26 g/1 MgS0 4 -H 2 0, 76 g/1 KH 2 P0 , and 50 ml/1 of trace metals; the trace metals are 40 mg/1 NaB 4 O 7 -10H 2 O, 400 mg/1 CuS0 -5H 2 0, 1200mg/l FeS0 -7H 2 0, 700mg/l MnS0 4 -H 2 0, 800mg/l Na 2 Mo0 2 -2H 2 0, 10 g/1 ZnSO -7H 2 0). After autoclaving, 10 ml/1 of 1M filtrated acetamide and 5-10 ml of 3M CsCl are added to the solution. Transformants are selected by growth cells on COVE medium which contains acetamide as the carbon source. The confirmation of laccase production in the samples is determined by the ABTS oxidation method as described above on Cove medium with 2 mM ABTS, at pH 5 and 7.3. Both RSlacl and RS2ac2 express laccase activity at pH 5 and pH 7, in contrast with a control laccase which shows substantially no activity at pH 7.3. The products of the expression of each of RSlacl and RS2ac2 are tested for oxidase activity at various pHs using syringaldazine as the substrate. The assay is conducted substantially as described above for the assay of the native protein, over pH range of 4-9. As shown in Figures 5 and 6, both laccases are active at pHs over pH 5, and RSlacl has particularly good activity at pHs over 6. The pattern of activity is generally comparable to that observed for the RS2ac3 laccase isolated from RS 22 (see Table 1 above) , with RSlacl exhibiting the broadest range of activity. Deposit of Biological Materials The following biological materials have been deposited under the terms of the Budapest Treaty in the International Mycological Institute, Genetic Resource Reference Collection, located at Bakeham Lane, Egham, Surrey TW20 9TY and given the following accession number. Deposit Accession Number Rhizoctonia solani RS22 IMI CC 358730 The following biological materials have been deposited under the terms of the Budapest Treaty with the Agricultural Research Service Patent Culture Collection, Northern Regional Research Center, 1815 University Street, Peoria, Illinois, 61604 and given the following accession numbers. Deposit Accession Number E. coli containing RSlacl fused to NRRL B-21141 an α-amylase signal sequence (EMCC 00844) E. coli containing RSlac2 with an NRRL B-21142 Sfil site insert (EMCC 00845) E. coli containing RS2ac3 NRRL B-21156 (.EMCC 0088) SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: (A) NAME: Novo Nordisk A/S (B) STREET: Novo Alle (C) CITY: Bagsva_rd (D) COUNTRY: Denmark (E) POSTAL CODE (ZIP) : DK-2880 (F) TELEPHONE: +45 4444 8888 (G) TELEFAX: +45 4449 3256 (F) TELEX: 37304 (i) APPLICANT: (A) NAME: Novo Nordisk Biotech, Inc. (B) STREET: 1445 Drew Avenue (C) CITY: Davis, California (D) COUNTRY: United States of America (E) POSTAL CODE (ZIP) : 95616-4880 (F) TELEPHONE: (916) 757-8100 (G) TELEFAX: (916) 758-0317 (ii) TITLE OF INVENTION: PURIFIED PH NEUTRAL LACCASES AND NUCLEIC ACIDS ENCODING SAME (iii) NUMBER OF SEQUENCES: 14 (iv) CORRESPONDENCE ADDRESS: (A) ADDRESSEE: Novo Nordisk of North America, Inc. (B) STREET: 405 Lexington Avenue, Suite 6400 (C) CITY: New York (D) STATE: New York (E) COUNTRY: USA (F) ZIP: 10174-6401 (v) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: PatentIn Release #1.0, Version #1.25 (vi) CURRENT APPLICATION DATA: (A) APPLICATION NUMBER: to be assigned (B) FILING DATE: 13-SEP-1994 (vii) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER: US 08/172,331 (B) FILING DATE: 22-DEC-1993 (vii) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER: US 08/122,230 (B) FILING DATE: 17-SEP-1993 (vii) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER: US 08/122,827 (B) FILING DATE: 17-SEP-1993 (vii) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER: US 08/162,827 (B) FILING DATE: 03-DEC-1993 (viii) ATTORNEY/AGENT INFORMATION: (A) NAME: Lowney Dr., Karen A. (B) REGISTRATION NUMBER: 31,274 (C) REFERENCE/DOCKET NUMBER: 4052.204-WO ( ix) TELECOMMUNICATION INFORMATION : (A) TELEPHONE: 212-867-0123 (B) TELEFAX: 212-878-9655 (2) INFORMATION FOR SEQ ID NO:l: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2838 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (A) ORGANISM: Rhizoctonia laccase (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 302..351 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 463..512 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 576..633 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 760..818 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 822..877 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 1001..1054 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 1316..1372 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 1697..1754 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 1827..1880 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 1992..2051 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 2157..2206 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 2348..2404 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 2438..2498 (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: join(170..301, 352..462, 513..575, 634..759, 819 ..821, 878..1000, 1055..1315, 1373..1696, 1755 ..1826, 1881..1991, 2052..2156, 2207..2347, 2405 ..2437, 2499..2621) (xi) SEQUENCE DESCRIPTION: SEQ ID Nθ:l: AGCGTCACAC CAGACATCGG ATGAAAACGG AAAGTGTATG CGCCATTTGA CGTCTGCGGC 60 AACCACTGTT CATCTCGCGA GCTAACATGG GCGACGTATA AGAAGAACGC GAGAATGGGC 120 AGATTTCGAT ATCCCCTCTC GTCTCGGTTT TGGTCTCGGC TTGCCTCTA ATG GCG 175 Met Ala 1 CGC ACC ACT TTC CTT GTC TCG GTT TCG CTC TTT GTT TCC GCT GTT CTT 223 Arg Thr Thr Phe Leu Val Ser Val Ser Leu Phe Val Ser Ala Val Leu 5 10 15 GCG CGC ACC GTC GAG TAC GGC TTG AAG ATT AGT GAT GGG GAG ATA GCT 271 Ala Arg Thr Val Glu Tyr Gly Leu Lys lie Ser Asp Gly Glu lie Ala 20 25 30 CCT GAC GGT GTT AAG CGT AAT GCG ACT TTG GTACGCACTC CTTGTAATCC 321 Pro Asp Gly Val Lys Arg Asn Ala Thr Leu 35 40 AACAATTCAA GGTTTCTGAT GCTTGGTCAG GTA AAT GGA GGG TAT CCC GGT CCA 375 Val Asn Gly Gly Tyr Pro Gly Pro 45 50 CTC ATT TTT GCC AAC AAG GGG GAT ACT CTC AAA GTC AAG GTC CAA AAC 423 Leu lie Phe Ala Asn Lys Gly Asp Thr Leu Lys Val Lys Val Gin Asn 55 60 65 AAG CTC ACG AAT CCT GAG ATG TAT CGC ACC ACT TCC ATC GTATGTTCGT 472 Lys Leu Thr Asn Pro Glu Met Tyr Arg Thr Thr Ser lie 70 75 80 TCGATATCTA CTAATACATC CGTCGCTAAA TATCTTGTAG CAT TGG CAC GGT CTC 527 His Trp His Gly Leu 85 TTA CAA CAT AGA AAC GCC GAC GAC GAC GGT CCT TCG TTC GTC ACT CAG 575 Leu Gin His Arg Asn Ala Asp Asp Asp Gly Pro Ser Phe Val Thr Gin 90 95 100 GTAGGATTCT GGAAGGTTGG CCTGAACTCT CTGTTAACCG ACAACCCGAT GTCACCAG 633 TGC CCG ATT GTT CCA CGC GAG TCG TAT ACT TAC ACC ATA CCT CTG GAC 681 Cys Pro lie Val Pro Arg Glu Ser Tyr Thr Tyr Thr lie Pro Leu Asp 105 110 115 GAT CAA ACC GGA ACC TAT TGG TAC CAT AGC CAC TTG AGT TCG CAA TAC 729 Asp Gin Thr Gly Thr Tyr Trp Tyr His Ser His Leu Ser Ser Gin Tyr 120 125 130 GTT GAT GGT CTT CGA GGC CCG CTG GTA ATC GTGAGTATCT TGACTTGTCT 779 Val Asp Gly Leu Arg Gly Pro Leu Val lie 135 140 ACTGAAGGCA ACGAGACTAA AAC AGCGTC GATTCACAG TAT GTTCGTCTCC 831 Tyr 145 CCTTTATTTA GCTCTGGATC TTCATTTCTC ACGTAATACA TGATAG GAT CCC AAG 886 Asp Pro Lys GAT CCT CAC AGG CGT TTG TAT GAT GTT GAC GAT GAG AAG ACC GTC CTG 934 Asp Pro His Arg Arg Leu Tyr Asp Val Asp Asp Glu Lys Thr Val Leu 150 155 160 ATC ATC GGT GAC TGG TAT CAT GAA TCG TCC AAG GCA ATC CTT GCT TCT 982 lie lie Gly Asp Trp Tyr His Glu Ser Ser Lys Ala lie Leu Ala Ser 165 170 175. 180 GGT AAC ATT ACC CGA CAG GTAAGTGATA CATGCCGGTC CCAGAAAAAT 1030 Gly Asn lie Thr Arg Gin 185 TCTCTAAATT CATTTTAATT ACAG CGA CCG GTC TCT GCC ACC ATC AAC GGC 1081 Arg Pro Val Ser Ala Thr lie Asn Gly 190 195 AAA GGT CGA TTT GAC CCT GAC AAC ACT CCT GCC AAC CCA GAT ACT CTG 1129 Lys Gly Arg Phe Asp Pro Asp Asn Thr Pro Ala Asn Pro Asp Thr Leu 200 205 210 TAC ACC CTC AAG GTC AAG CGA GGG AAG CGC TAT CGT CTG CGT GTC ATC 1177 Tyr Thr Leu Lys Val Lys Arg Gly Lys Arg Tyr Arg Leu Arg Val lie 215 220 225 AAT AGC TCG GAG ATC GCT TCG TTC CGA TTC AGT GTG GAA GGT CAC AAG 1225 Asn Ser Ser Glu lie Ala Ser Phe Arg Phe Ser Val Glu Gly His Lys 230 235 240 GTG ACT GTG ATT GCT GCC GAT GGC GTC TCT ACC AAA CCG TAT CAG GTC 1273 Val Thr Val lie Ala Ala Asp Gly Val Ser Thr Lys Pro Tyr Gin Val 245 250 255 GAT GCG TTT GAT ATT CTA GCA GGA CAG CGC ATA GAT TGC GTC 1315 Asp Ala Phe Asp lie Leu Ala Gly Gin Arg lie Asp Cys Val 260 265 270 GTAAGTGTCG TCCGAACCCA CATCTGAGCT CAAGTGTTGA TACATGCGCG CTTATAG 1372 GTG GAG GCG AAC CAA GAA CCC GAC ACA TAC TGG ATC AAC GCA CCG CTG 1420 Val Glu Ala Asn Gin Glu Pro Asp Thr Tyr Trp lie Asn Ala Pro Leu 275 280 285 ACC AAC GTG CCC AAC AAG ACC GCT CAG GCT CTC CTC GTT TAT GAG GAG 1468 Thr Asn Val Pro Asn Lys Thr Ala Gin Ala Leu Leu Val Tyr Glu Glu 290 295 300 305 GAT CGT CGG CCG TAC CAC CCT CCA AAG GGC CCG TAT CGC AAG TGG AGC 1516 Asp Arg Arg Pro Tyr His Pro Pro Lys Gly Pro Tyr Arg Lys Trp Ser 310 315 320 GTC TCT GAG GCG ATC ATC AAG TAC TGG AAT CAC AAG CAC AAG CAC GGA 1564 Val Ser Glu Ala lie lie Lys Tyr Trp Asn His Lys His Lys His Gly 325 330 335 CGT GGT TTG CTG TCT GGA CAT GGA GGT CTC AAG GCT CGG ATG ATC GAG 1612 Arg Gly Leu Leu Ser Gly His Gly Gly Leu Lys Ala Arg Met lie Glu 340 345 350 GGT AGC CAT CAT CTG CAT TCG CGC AGC GTC GTT AAG CGC CAG AAT GAG 1660 Gly Ser His His Leu His Ser Arg Ser Val Val Lys Arg Gin Asn Glu 355 360 365 ACC ACC ACT GTT GTA ATG GAC GAG AGC AAG CTC GTT GTAAGTACCA 1706 Thr Thr Thr Val Val Met Asp Glu Ser Lys Leu Val 370 375 380 TATTTAAAAG TTGGTTGGGT TTCGAATACT TATTTCAACT TTTCTTAG CCA CTG GAA 1763 Pro Leu Glu TAC CCC GGC GCT GCA TGC GGG TCT AAA CCT GCT GAC CTC GTC TTG GAT 1811 Tyr Pro Gly Ala Ala Cys Gly Ser Lys Pro Ala Asp Leu Val Leu Asp 385 390 395 400 CTC ACT TTT GGT TTG GTATGTAGCC AAATCGCCCA TATACAGGAT ACTGAATATT 1866 Leu Thr Phe Gly Leu 405 GTTTGTGCGT GTAG AAC TTT GCT ACC GGG CAC TGG ATG ATC AAC GGT ATC 1916 Asn Phe Ala Thr Gly His Trp Met lie Asn Gly lie 410 415 CCA TAC GAG TCT CCC AAA ATC CCC ACA TTG CTC AAG ATC CTC ACT GAT 1964 Pro Tyr Glu Ser Pro Lys lie Pro Thr Leu Leu Lys lie Leu Thr Asp 420 425 430 GAG GAC GGG GTT ACC GAG TCT GAC TTC GTATGTTCCC TTTTCGGTAT 2011 Glu Asp Gly Val Thr Glu Ser Asp Phe 435 440 CTTCGTATGC GTGCACTGAC TCGTGCTGGT GGGAATTTAG ACC AAG GAG GAG CAC 2066 Thr Lys Glu Glu His 445 ACA GTC ATA CTC CCG AAG AAC AAA TGC ATC GAA TTC AAC ATC AAG GGG 2114 Thr Val lie Leu Pro Lys Asn Lys Cys lie Glu Phe Asn lie Lys Gly 450 455 460 AAC TCG GGT ATT CCC ATT ACG CAC CCC GTA CAT CTT CAC GGT 2156 Asn Ser Gly lie Pro lie Thr His Pro Val His Leu His Gly 465 470 475 GTAAGTGCAT ATCGGATGGT TTACGATACT AAGGCTCATC AACTTTTTAG CAC ACT 2212 His Thr TGG GAT GTC GTA CAA TTT GGC AAC AAC CCA CCC AAT TAT GTC AAT CCT 2260 Trp Asp Val Val Gin Phe Gly Asn Asn Pro Pro Asn Tyr Val Asn Pro 480 485 490 495 CCC CGT AGG GAC GTG GTT GGC TCT ACA GAT GCG GGT GTG AGG ATT CAG 2308 Pro Arg Arg Asp Val Val Gly Ser Thr Asp Ala Gly Val Arg lie Gin 500 505 510 TTC AAG ACC GAC AAT CCA GGA CCG TGG TTC CTG CAC TGC GTGCGTCGGT 2357 Phe Lys Thr Asp Asn Pro Gly Pro Trp Phe Leu His Cys 515 520 CCCCATCGTC CGTTATGGTT TTTCTAATAC GTCCCATTCT ATTTTAG CAT ATT GAC 2413 His lie Asp 525 TGG CAT CTT GAG GAG GGT TTC GCA GTGAGTACTG AGACCTAAGT GCTACTCGGC 2467 Trp His Leu Glu Glu Gly Phe Ala 530 535 TCATTACTGA TTACCGCATG TATGCGTCTA G ATG GTG TTT GCT GAA GCG CCC 2519 Met Val Phe Ala Glu Ala Pro 540 GAA GCC GTC AAG GGA GGT CCA AAG AGC GTG GCC GTG GAC TCT CAG TGG 2567 Glu Ala Val Lys Gly Gly Pro Lys Ser Val Ala Val Asp Ser Gin Trp 545 550 555 GAA GGG CTG TGT GGC AAG TAC GAC AAC TGG CTA AAA TCA AAT CCG GGC 2615 Glu Gly Leu Cys Gly Lys Tyr Asp Asn Trp Leu Lys Ser Asn Pro Gly 560 565 570 CAG CTG TAGGCGTATC GCAGCCACAT TGGTGATGAT TGAAAGTTGC ATCTTGTTCC 2671 Gin Leu 575 TATAACCGGC TCTTATATAC GGGTGTCTCC CAGTAAAGTC GTAGCCCAAT TTCAGCCGAG 2731 ACAGATATTT AGTGGACTCT TACTCTTGTG TCCCATTGAC GCACATCGTT GCATCAAACC 2791 TGCTTTTTAT CGTCCCTCTT TGTAATTTGT GTTGCTGTAA TGTATCG 2838 (2) INFORMATION FOR SEQ ID NO:2: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 576 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID Nθ:2: Met Ala Arg Thr Thr Phe Leu Val Ser Val Ser Leu Phe Val Ser Ala 1 5 10 15 Val Leu Ala Arg Thr Val Glu Tyr Gly Leu Lys lie Ser Asp Gly Glu 20 25 30 lie Ala Pro Asp Gly Val Lys Arg Asn Ala Thr Leu Val Asn Gly Gly 35 40 45 Tyr Pro Gly Pro Leu lie Phe Ala Asn Lys Gly Asp Thr Leu Lys Val 50 55 60 Lys Val Gin Asn Lys Leu Thr Asn Pro Glu Met Tyr Arg Thr Thr Ser 65 70 75 80 lie His Trp His Gly Leu Leu Gin His Arg Asn Ala Asp Asp Asp Gly 85 90 95 Pro Ser Phe Val Thr Gin Cys Pro lie Val Pro Arg Glu Ser Tyr Thr 100 105 110 Tyr Thr lie Pro Leu Asp Asp Gin Thr Gly Thr Tyr Trp Tyr His Ser 115 120 125 His Leu Ser Ser Gin Tyr Val Asp Gly Leu Arg Gly Pro Leu Val lie 130 135 140 Tyr Asp Pro Lys Asp Pro His Arg Arg Leu Tyr Asp Val Asp Asp Glu 145 150 155 160 Lys Thr Val Leu lie lie Gly Asp Trp Tyr His Glu Ser Ser Lys Ala 165 170 175 lie Leu Ala Ser Gly Asn lie Thr Arg Gin Arg Pro Val Ser Ala Thr 180 185 190 lie Asn Gly Lys Gly Arg Phe Asp Pro Asp Asn Thr Pro Ala Asn Pro 195 200 205 Asp Thr Leu Tyr Thr Leu Lys Val Lys Arg Gly Lys Arg Tyr Arg Leu 210 215 220 Arg Val lie Asn Ser Ser Glu lie Ala Ser Phe Arg Phe Ser Val Glu 225 230 235 240 Gly His Lys Val Thr Val lie Ala Ala Asp Gly Val Ser Thr Lys Pro 245 250 255 Tyr Gin Val Asp Ala Phe Asp lie Leu Ala Gly Gin Arg lie Asp Cys 260 265 270 Val Val Glu Ala Asn Gin Glu Pro Asp Thr Tyr Trp lie Asn Ala Pro 275 280 285 Leu Thr Asn Val Pro Asn Lys Thr Ala Gin Ala Leu Leu Val Tyr Glu 290 295 300 Glu Asp Arg Arg Pro Tyr His Pro Pro Lys Gly Pro Tyr Arg Lys Trp 305 310 ' 315 320 Ser Val Ser Glu Ala lie lie Lys Tyr Trp Asn His Lys His Lys His 325 330 335 Gly Arg Gly Leu Leu Ser Gly His Gly Gly Leu Lys Ala Arg Met lie 340 345 350 Glu Gly Ser His His Leu His Ser Arg Ser Val Val Lys Arg Gin Asn 355 360 365 Glu Thr Thr Thr Val Val Met Asp Glu Ser Lys Leu Val Pro Leu Glu 370 375 380 Tyr Pro Gly Ala Ala Cys Gly Ser Lys Pro Ala Asp Leu Val Leu Asp 385 390 395 400 Leu Thr Phe Gly Leu Asn Phe Ala Thr Gly His Trp Met lie Asn Gly 405 410 415 lie Pro Tyr Glu Ser Pro Lys lie Pro Thr Leu Leu Lys lie Leu Thr 420 425 430 Asp Glu Asp Gly Val Thr Glu Ser Asp Phe Thr Lys Glu Glu His Thr 435 440 445 Val lie Leu Pro Lys Asn Lys Cys lie Glu Phe Asn lie Lys Gly Asn 450 455 460 Ser Gly lie Pro lie Thr His Pro Val His Leu His Gly His Thr Trp 465 470 475 480 Asp Val Val Gin Phe Gly Asn Asn Pro Pro Asn Tyr Val Asn Pro Pro 485 490 495 Arg Arg Asp Val Val Gly Ser Thr Asp Ala Gly Val Arg lie Gin Phe 500 505 510 Lys Thr Asp Asn Pro Gly Pro Trp Phe Leu His Cys His lie Asp Trp 515 520 525 His Leu Glu Glu Gly Phe Ala Met Val Phe Ala Glu Ala Pro Glu Ala 530 535 540 Val Lys Gly Gly Pro Lys Ser Val Ala Val Asp Ser Gin Trp Glu Gly 545 550 555 560 Leu Cys Gly Lys Tyr Asp Asn Trp Leu Lys Ser Asn Pro Gly Gin Leu 565 570 575 (2) INFORMATION FOR SEQ ID Nθ:3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3117 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (A) ORGANISM: Rhizoctonia laccase (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: join(393..524, 577..687, 737..799, 860..985, 1043 ..1045, 1097..1219, 1269..1538, 1601..1996, 2047 ..2118, 2174..2284, 2338..2439, 2495..2635, 2693 ..2725, 2786..2899) (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 525..576 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 688..736 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 800..859 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 986..1042 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 1220..1268 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 1539..1600 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 1823..1936 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 1973..2046 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 2119..2173 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 2285.-2337 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 2440..2494 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 2636.-2692 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 1046..1096 (xi) SEQUENCE DESCRIPTION: SEQ ID Nθ:3: GAGTGATCCG CCAGAGTTCA GGCGGATAAG TTCCTAAATA GTCATTCGCC TATTCGTGTA 60 CCTCAGCATA CTGACGACAT ACCGCCAGAT CGCCCTCGGT TCGGGCGTGG CATACGTTCG 120 CAAGGGCACC TCACGGAGCA AACTCTAAAA AGCTTCGGCA TGGATTGCAT TTTGTATTGT 180 AAACAAGTTA CGAGAAAAAC AATAGATCAG TTTTTGCCGA ATCGGATGGC TTGAAACGGA 240 AGTACCGATG GCCGATCCGA GTCGAATGAA TTAACGCATC TGAAACGGGA CCCTGAGTCG 300 AGGCACCCGC CGGCCTTGGC CGTATAAGTC ACTTGTCGCC AACTAGCACT TTTTCATTCC 360 CCCTTTTCTT CTTCCTCGTC TTCTTCTTCT CT ATG GCT CGG TCG ACT ACT TCA 413 Met Ala Arg Ser Thr Thr Ser 1 5 CTC TTT GCA CTG TCT CTC GTT GCT TCA GCG TTT GCT CGA GTC GTT GAC 461 Leu Phe Ala Leu Ser Leu Val Ala Ser Ala Phe Ala Arg Val Val Asp 10 15 20 TAT GGG TTT GAT GTG GCT AAT GGG GCA GTT GCT CCG GAT GGT GTA ACA 509 Tyr Gly Phe Asp Val Ala Asn Gly Ala Val Ala Pro Asp Gly Val Thr 25 30 35 AGG AAC GCG GTT CTC GTGAGTTAGC TGTAAGATGG TGTATATGCT GGTTGCCTAA 564 Arg Asn Ala Val Leu 40 CGGGAATGTC AG GTC AAT GGT CGC TTC CCT GGT CCA TTG ATC ACC GCC 612 Val Asn Gly Arg Phe Pro Gly Pro Leu lie Thr Ala 45 50 55 AAC AAG GGG GAT ACA CTT AAA ATC ACC GTG CGG AAT AAA CTC TCC GAT 660 Asn Lys Gly Asp Thr Leu Lys lie Thr Val Arg Asn Lys Leu Ser Asp 60 65 70 CCA ACT ATG CGA AGG AGC ACG ACC ATC GTTAGTACTT CCCCTCATCT 707 Pro Thr Met Arg Arg Ser Thr Thr lie 75 80 GTCTTGAAAC TTTCTCATCT TTTTTGAAG CAC TGG CAC GGT CTG CTC CAA CAC 760 His Trp His Gly Leu Leu Gin His 85 AGG ACG GCA GAA GAA GAT GGC CCG GCC TTT GTA ACC CAG GTATGCCTTA 809 Arg Thr Ala Glu Glu Asp Gly Pro Ala Phe Val Thr Gin 90 95 100 TCCTATCGCT GCTCTGTCCC CGCGTCCTTC CCTGACTCGG GCGATTCTAG TGC CCG 865 Cys Pro ATT CCT CCG CAA GAA TCG TAC ACC TAT ACG ATG CCG CTC GGC GAA CAG 913 lie Pro Pro Gin Glu Ser Tyr Thr Tyr Thr Met Pro Leu Gly Glu Gin 105 110 115 120 ACC GGC ACG TAT TGG TAC CAC AGC CAC TTG AGC TCC CAG TAT GTG GAC 961 Thr Gly Thr Tyr Trp Tyr His Ser His Leu Ser Ser Gin Tyr Val Asp 125 130 135 GGG TTG CGT GGG CCC ATC GTT ATT GTAAGTCTTC ATTTAACCTT ATTCTTGGTT 1015 Gly Leu Arg Gly Pro lie Val lie 140 ATGGCTGATT GTGACGTCGT GGTTAGT ATG TTCGTGGCTT CCACAAGAAG 1065 Met 145 TCAGCAGCCC TTGAAGCTAA CTTTATTCCA G GAC CCC CAC GAC CCG TAC AGA 1117 Asp Pro His Asp Pro Tyr Arg 150 AAC TAC TAT GAT GTC GAC GAC GAG CGT ACG GTC TTT ACT TTA GCA GAC 1165 Asn Tyr Tyr Asp Val Asp Asp Glu Arg Thr Val Phe Thr Leu Ala Asp 155 160 165 TGG TAC CAC ACG CCG TCG GAG GCT ATC ATT GCC ACC CAC GAT GTC TTG 1213 Trp Tyr His Thr Pro Ser Glu Ala lie lie Ala Thr His Asp Val Leu 170 175 180 AAA ACG GTACGCGTTA ATCCTTCTAG CTTTCTTTCC TTGGGTCACT TTCTATCAG 1268 Lys Thr 185 ATC CCC GAC TCG GGT ACG ATC AAC GGC AAA GGC AAA TAC GAT CCT GCT 1316 lie Pro Asp Ser Gly Thr lie Asn Gly Lys Gly Lys Tyr Asp Pro Ala 190 195 200 TCG GCT AAC ACC AAC AAC ACG ACA CTC GAG AAC CTC TAC ACT CTC AAA 1364 Ser Ala Asn Thr Asn Asn Thr Thr Leu Glu Asn Leu Tyr Thr Leu Lys 205 210 215 GTC AAA CGC GGC AAG CGG TAT CGC CTG AGG ATT ATC AAC GCC TCG GCC 1412 Val Lys Arg Gly Lys Arg Tyr Arg Leu Arg lie lie Asn Ala Ser Ala 220 225 230 ATC GCT TCG TTC CGG TTC GGC GTG CAG GGC CAC AAG TGC ACG ATC ATC 1460 lie Ala Ser Phe Arg Phe Gly Val Gin Gly His Lys Cys Thr lie lie 235 240 245 250 GAG GCT GAT GGC GTC CTC ACC AAA CCG ATC GAG GTC GAT GCG TTT GAT 1508 Glu Ala Asp Gly Val Leu Thr Lys Pro lie Glu Val Asp Ala Phe Asp 255 260 265 ATT CTA GCA GGC CAG AGG TAT AGC TGC ATC GTAAGTCTAC CTATGCCTTG 1558 lie Leu Ala Gly Gin Arg Tyr Ser Cys lie 270 275 TTGTGGAGAT AAGAACCTGA CTGAATGTAT GCGCTCCAAT AG TTG AAG GCC GAC 1612 Leu Lys Ala Asp 280 CAA GAT CCT GAT TCC TAC TGG ATA AAT GCG CCA ATC ACA AAC GTT CTC 1660 Gin Asp Pro Asp Ser Tyr Trp lie Asn Ala Pro lie Thr Asn Val Leu 285 290 295 AAC ACC AAC GTC CAG GCA TTG CTA GTG TAT GAA GAT GAC AAG CGT CCT 1708 Asn Thr Asn Val Gin Ala Leu Leu Val Tyr Glu Asp Asp Lys Arg Pro 300 305 310 ACT CAC TAC CCC TGG AAG CCG TTT TTG ACA TGG AAG ATA TCA AAT GAA 1756 Thr His Tyr Pro Trp Lys Pro Phe Leu Thr Trp Lys lie Ser Asn Glu 315 320 325 ATC ATT CAG TAC TGG CAG CAC AAG CAC GGG TCG CAC GGT CAC AAG GGA 1804 lie lie Gin Tyr Trp Gin His Lys His Gly Ser His Gly His Lys Gly 330 335 340 AAG GGG CAT CAT CAT AAA GTC CGG GCC ATT GGA GGT GTA TCC GGG TTG 1852 Lys Gly His His His Lys Val Arg Ala lie Gly Gly Val Ser Gly Leu 345 350 355 360 AGC TCC AGG GTT AAG AGC CGG GCG AGT GAC CTA TCG AAG AAG GCT GTC 1900 Ser Ser Arg Val Lys Ser Arg Ala Ser Asp Leu Ser Lys Lys Ala Val 365 370 375 GAG TTG GCT GCT GCA CTC GTT GCG GGT GAG GCC GAG TTG GAC AAG AGG 1948 Glu Leu Ala Ala Ala Leu Val Ala Gly Glu Ala Glu Leu Asp Lys Arg 380 385 390 CAG AAT GAG GAT AAT TCG ACT ATT GTA TTG GAT GAG ACC AAG CTT ATT 1996 Gin Asn Glu Asp Asn Ser Thr lie Val Leu Asp Glu Thr Lys Leu He 395 400 405 GTAAGTCCCT TAATTTTTTT CGGTGTCACG GAAGCTAACC CGCGTAATAG CCG TTG 2052 Pro Leu 410 GTT CAA CCT GGT GCA CCG GGC GGC TCC AGA CCA GCT GAC GTC GTG GTC 2100 Val Gin Pro Gly Ala Pro Gly Gly Ser Arg Pro Ala Asp Val Val Val 415 420 425 CCT CTG GAC TTT GGC CTC GTATGTGGCT TCTTGTTATT CGTCCGGAAT 2148 Pro Leu Asp Phe Gly Leu 430 GCAAACTGAT TTGGGTGGGC TATAG AAC TTT GCC AAC GGA CTG TGG ACG ATA 2200 Asn Phe Ala Asn Gly Leu Trp Thr He 435 440 AAC AAT GTC TCC TAC TCC CCT CCG GAT GTC CCT ACT CTC CTC AAG ATC 2248 Asn Asn Val Ser Tyr Ser Pro Pro Asp Val Pro Thr Leu Leu Lys He 445 450 455 TTG ACC GAC AAA GAC AAA GTC GAC GCT TCT GAC TTC GTAGGTTCCT 2294 Leu Thr Asp Lys Asp Lys Val Asp Ala Ser Asp Phe 460 465 CTTCTTCTTT TCAAACTAGC TACTGACATT AAGTGAACGT CAG ACG GCC GAT GAA 2349 Thr Ala Asp Glu 470 CAC ACG TAT ATT CTT CCA AAG AAC CAA GTT GTC GAG TTG CAC ATC AAG 2397 His Thr Tyr He Leu Pro Lys Asn Gin Val Val Glu Leu His He Lys 475 480 485 GGA CAG GCT TTG GGA ATC GTA CAC CCC CTT CAT CTG CAT GGC 2439 Gly Gin Ala Leu Gly He Val His Pro Leu His Leu His Gly 490 495 500 GTACGTCTTT CTCACACTGT TCCAGCTCCT ATTCTCTAAC ACACTCCTGC GATAG CAT 2497 His GCG TTC GAC GTC GTC CAA TTC GGC GAC AAC GCT CCA AAC TAC GTG AAC 2545 Ala Phe Asp Val Val Gin Phe Gly Asp Asn Ala Pro Asn Tyr Val Asn 505 510 515 520 CCT CCG CGT AGG GAT GTA GTA GGC GTA ACT GAT GCT GGA GTC CGT ATC 2593 Pro Pro Arg Arg Asp Val Val Gly Val Thr Asp Ala Gly Val Arg He 525 530 535 CAG TTC AGA ACC GAT AAC CCG GGC CCT TGG TTC CTC CAT TGC 2635 Gin Phe Arg Thr Asp Asn Pro Gly Pro Trp Phe Leu His Cys 540 545 550 GTATGCTCTT CATCTCCC C CGCTTGTTCT TTACTTATGG TTTACCTTGC GATTTAG 2692 CAC ATT GAT TGG CAC TTG GAA GAA GGA TTT GCT GTAAGTTATT ATTCCTATTC 2745 His He Asp Trp His Leu Glu Glu Gly Phe Ala 555 560 CGAAGCATCG GGGAGATGCT AACCAAGGGT GTGTTTTAAG ATG GTA TTC GCC GAA 2800 Met Val Phe Ala Glu 565 GCG CCT GAA GAT ATC AAG AAA GGC TCT CAG AGT GTC AAG CCT GAC GGA 2848 Ala Pro Glu Asp He Lys Lys Gly Ser Gin Ser Val Lys Pro Asp Gly 570 575 580 CAA TGG AAG AAA CTA TGC GAG AAG TAT GAG AAG TTG CCT GAA GCA CTG 2896 Gin Trp Lys Lys Leu Cys Glu Lys Tyr Glu Lys Leu Pro Glu Ala Leu 585 590 595 CAG TGAAGTTGCA GTTGTTTCCC ATTCGGGAAC TGGCTCACTA TTCCTTTTGC 2949 Gin ATAATTCGGA CTTTTATTTT GGGACATTAT TGGACTATGG ACTTGTTTGT CACACCCTCG 3009 CTCACTGTGT CCCTCGTTGA GTACCTATAC TCTATTCGTA TAGTGGGAAT ATGGAATATC 3069 GGATGTAATA AATGCTCGTG CGTTTGGTGC TCGAAATGGG GTAGGACT 3117 (2) INFORMATION FOR SEQ ID NO:4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 599 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4: Met Ala Arg Ser Thr Thr Ser Leu Phe Ala Leu Ser Leu Val Ala Ser 1 5 10 15 Ala Phe Ala Arg Val Val Asp Tyr Gly Phe Asp Val Ala Asn Gly Ala 20 25 30 Val Ala Pro Asp Gly Val Thr Arg Asn Ala Val Leu Val Asn Gly Arg 35 40 45 Phe Pro Gly Pro Leu He Thr Ala Asn Lys Gly Asp Thr Leu Lys He 50 55 60 Thr Val Arg Asn Lys Leu Ser Asp Pro Thr Met Arg Arg Ser Thr Thr 65 70 75 80 He His Trp His Gly Leu Leu Gin His .Arg Thr Ala Glu Glu Asp Gly 85 90 95 Pro Ala Phe Val Thr Gin Cys Pro He Pro Pro Gin Glu Ser Tyr Thr 100 105 110 Tyr Thr Met Pro Leu Gly Glu Gin Thr Gly Thr Tyr Trp Tyr His Ser 115 120 125 His Leu Ser Ser Gin Tyr Val Asp Gly Leu Arg Gly Pro He Val He 130 135 140 Met Asp Pro His Asp Pro Tyr Arg Asn Tyr Tyr Asp Val Asp Asp Glu 145 150 155 160 Arg Thr Val Phe Thr Leu Ala Asp Trp Tyr His Thr Pro Ser Glu Ala 165 170 175 He He Ala Thr His Asp Val Leu Lys Thr He Pro Asp Ser Gly Thr 180 185 190 He Asn Gly Lys Gly Lys Tyr Asp Pro Ala Ser Ala Asn Thr Asn Asn 195 200 205 Thr Thr Leu Glu Asn Leu Tyr Thr Leu Lys Val Lys Arg Gly Lys Arg 210 215 220 Tyr Arg Leu Arg He He Asn Ala Ser Ala He Ala Ser Phe Arg Phe 225 230 235 240 Gly Val Gin Gly His Lys Cys Thr He He Glu Ala Asp Gly Val Leu 245 250 255 Thr Lys Pro He Glu Val Asp Ala Phe Asp He Leu Ala Gly Gin Arg 260 265 270 Tyr Ser Cys He Leu Lys Ala Asp Gin Asp Pro Asp Ser Tyr Trp He 275 280 285 Asn Ala Pro He Thr Asn Val Leu Asn Thr Asn Val Gin Ala Leu Leu 290 295 300 Val Tyr Glu Asp Asp Lys Arg Pro Thr His Tyr Pro Trp Lys Pro Phe 305 310 315 320 Leu Thr Trp Lys He Ser Asn Glu He He Gin Tyr Trp Gin His Lys 325 330 335 His Gly Ser His Gly His Lys Gly Lys Gly His His His Lys Val Arg 340 345 350 Ala He Gly Gly Val Ser Gly Leu Ser Ser Arg Val Lys Ser Arg Ala 355 360 365 Ser Asp Leu Ser Lys Lys Ala Val Glu Leu Ala Ala Ala Leu Val Ala 370 375 380 Gly Glu Ala Glu Leu Asp Lys Arg Gin Asn Glu Asp Asn Ser Thr He 385 390 395 400 Val Leu Asp Glu Thr Lys Leu He Pro Leu Val Gin Pro Gly Ala Pro 405 410 415 Gly Gly Ser Arg Pro Ala Asp Val Val Val Pro Leu Asp Phe Gly Leu 420 425 430 Asn Phe Ala Asn Gly Leu Trp Thr He Asn Asn Val Ser Tyr Ser Pro 435 440 445 Pro Asp Val Pro Thr Leu Leu Lys He Leu Thr Asp Lys Asp Lys Val 450 455 460 Asp Ala Ser Asp Phe Thr Ala Asp Glu His Thr Tyr He Leu Pro Lys 465 470 475 480 Asn Gin Val Val Glu Leu His He Lys Gly Gin Ala Leu Gly He Val 485 490 495 His Pro Leu His Leu His Gly His Ala Phe Asp Val Val Gin Phe Gly 500 505 510 Asp Asn Ala Pro Asn Tyr Val Asn Pro Pro Arg Arg Asp Val Val Gly 515 520 525 Val Thr Asp Ala Gly Val Arg He Gin Phe Arg Thr Asp Asn Pro Gly 530 535 540 Pro Trp Phe Leu His Cys His He Asp Trp His Leu Glu Glu Gly Phe 545 550 555 560 Ala Met Val Phe Ala Glu Ala Pro Glu Asp He Lys Lys Gly Ser Gin 565 570 575 Ser Val Lys Pro Asp Gly Gin Trp Lys Lys Leu Cys Glu Lys Tyr Glu 580 585 590 Lys Leu Pro Glu Ala Leu Gin 595 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5: Ala Val Arg Asn Tyr Lys Phe Asp He Lys Asn Val Asn Val Ala Pro 1 5 10 15 Asp Gly Phe Gin Arg Pro He Val Ser Val 20 25 (2) INFORMATION FOR SEQ ID NO:6: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6: Ser Gin Tyr Val Asp Gly Leu Arg Gly Pro Leu Val He Tyr Asp Pro 1 5 10 15 Asp Asp Asp His 20 (2) INFORMATION FOR SEQ ID Nθ:7: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7: Ser Arg Tyr Asx Val Asx Asx Ala Ser Thr Val Val Met Leu Glu Asx 1 5 10 15 Trp Tyr Arg Thr Pro Ala Xaa Val Leu Glu 20 25 (2) INFORMATION FOR SEQ ID NO:8: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8: Ser Leu Gly Pro Thr Pro Asn Tyr Val Asn Pro Xaa He Arg Asp Val 1 5 10 15 Val Arg Val Gly Gly Thr Thr Val Val 20 25 (2) INFORMATION FOR SEQ ID NO:9: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9: Gly Leu Ala Leu Val Phe Ala Glu Ala Pro Ser Gin He Arg Gin Gly 1 5 10 15 Val Gin Ser Val Gin Pro Asp Asp Ala 20 25 (2) INFORMATION FOR SEQ ID NO:10: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 14 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide ( i) SEQUENCE DESCRIPTION: SEQ ID NO:10: He Arg Tyr Val Gly Gly Pro Ala Val Xaa Arg Ser Val He 1 5 10 (2) INFORMATION FOR SEQ ID NO:11: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide ( i) SEQUENCE DESCRIPTION: SEQ ID NO:11: He Leu Ala Asn Pro Ala 1 5 (2) INFORMATION FOR SEQ ID NO:12: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 8 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) . TOPOLOGY: 1inear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:12: Tyr Glu Ala Pro Ser Leu Pro Thr 1 5 (2) INFORMATION FOR SEQ ID NO:13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1912 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (vi) ORIGINAL SOURCE: (A) ORGANISM: Rhizoctonia laccase (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 85..1671 ( i) SEQUENCE DESCRIPTION: SEQ ID Nθ:13: CTAACGCTTG GTGCCGAGCT CGGATCCACT AGTAACGCGC GCCAGTGTGC TGGAATTCGC 60 GGCCGCGTCG ACACCTCCTT C AG ATG CTT TCT AGC ATT ACC CTC CTA CCT 111 Met Leu Ser Ser He Thr Leu Leu Pro 1 5 TTG CTC GCT GCG GTC TCA ACC CCC GCC TTT GCT GCC GTC CGC AAC TAT 159 Leu Leu Ala Ala Val Ser Thr Pro Ala Phe Ala Ala Val Arg Asn Tyr 10 15 20 25 AAG TTC GAC ATC AAG AAC GTC AAT GTC GCT CCC GAT GGC TTT CAG CGC 207 Lys Phe Asp He Lys Asn Val Asn Val Ala Pro Asp Gly Phe Gin Arg 30 35 40 TCT ATC GTC TCC GTC AAC GGT TTA GTT CCT GGC ACG TTG ATC ACG GCC 255 Ser He Val Ser Val Asn Gly Leu Val Pro Gly Thr Leu He Thr Ala 45 50 55 AAC AAG GGT GAC ACC TTG CGC ATT AAT GTC ACG AAT CAA CTC ACG GAC 303 Asn Lys Gly Asp Thr Leu Arg He Asn Val Thr Asn Gin Leu Thr Asp 60 65 70 CCT AGT ATG CGT CGT GCC ACA ACG ATT CAT TGG CAT GGA TTG TTC CAA 351 Pro Ser Met Arg Arg Ala Thr Thr He His Trp His Gly Leu Phe Gin 75 80 85 GCT ACT ACC GCC GAC GAG GAT GGC CCC GCA TTC GTC ACG CAA TGC CCT 399 Ala Thr Thr Ala Asp Glu Asp Gly Pro Ala Phe Val Thr Gin Cys Pro 90 95 100 105 ATT GCG CAA AAT TTG TCC TAT ACA TAC GAG ATC CCA TTG CGC GGC CAA 447 He Ala Gin Asn Leu Ser Tyr Thr Tyr Glu He Pro Leu Arg Gly Gin 110 115 120 ACA GGA ACC ATG TGG TAT CAC GCC CAT CTT GCG AGT CAA TAT GTC GAT 495 Thr Gly Thr Met Trp Tyr His Ala His Leu Ala Ser Gin Tyr Val Asp 125 130 135 GGA TTG CGA GGC CCT TTG GTC ATC TAT GAT CCA AAC GAC CCA CAC AAG 543 Gly Leu Arg Gly Pro Leu Val He Tyr Asp Pro Asn Asp Pro His Lys 140 145 150 TCG CGC TAC GAC GTG GAT GAT GCG AGC ACA GTA GTC ATG CTT GAG GAC 591 Ser Arg Tyr Asp Val Asp Asp Ala Ser Thr Val Val Met Leu Glu Asp 155 160 165 TGG TAC CAT ACT CCG GCA CCC GTT CTA GAA AAG CAA ATG TTC TCG ACT 639 Trp Tyr His Thr Pro Ala Pro Val Leu Glu Lys Gin Met Phe Ser Thr 170 175 180 185 AAT AAC ACC GCT CTG CTC TCT CCT GTT CCG GAC TCG GGT CTT ATC AAT 687 Asn Asn Thr Ala Leu Leu Ser Pro Val Pro Asp Ser Gly Leu He Asn 190 195 200 GGC AAA GGG CGC TAT GTG GGC GGT CCC GCA GTT CCC CGG TCA GTA ATC 735 Gly Lys Gly Arg Tyr Val Gly Gly Pro Ala Val Pro Arg Ser Val He 205 210 215 AAC GTA AAA CGT GGG AAA CGA TAT CGC TTG CGC GTA ATC AAC GCT TCT 783 Asn Val Lys Arg Gly Lys Arg Tyr Arg Leu Arg Val He Asn Ala Ser 220 225 230 GCT ATC GGG TCG TTT ACC TTT TCG ATC GAA GGA CAT AGT CTG ACT GTC 831 Ala He Gly Ser Phe Thr Phe Ser He Glu Gly His Ser Leu Thr Val 235 240 245 ATT GAG GCC GAT GGG ATC CTG CAC CAG CCC TTG GCT GTT GAC AGC TTC 879 He Glu Ala Asp Gly He Leu His Gin Pro Leu Ala Val Asp Ser Phe 250 255 260 265 CAG ATT TAC GCT GGA CAA CGC TAC TCT GTC ATC GTT GAA GCC AAC CAA 927 Gin He Tyr Ala Gly Gin Arg Tyr Ser Val He Val Glu Ala Asn Gin 270 275 280 ACC GCC GCC AAC TAC TGG ATT CGT GCA CCA ATG ACC GTT GCA GGA GCC 975 Thr Ala Ala Asn Tyr Trp He Arg Ala Pro Met Thr Val Ala Gly Ala 285 290 295 GGA ACC AAT GCA AAC TTG GAC CCC ACC AAT GTC TTT GCC GTA TTG CAC 1023 Gly Thr Asn Ala Asn Leu Asp Pro Thr Asn Val Phe Ala Val Leu His 300 305 310 TAC GAG GGA GCG CCC AAC GCC GAA CCC ACG ACG GAA CAA GGC AGT GCT 1071 Tyr Glu Gly Ala Pro Asn Ala Glu Pro Thr Thr Glu Gin Gly Ser Ala 315 320 325 ATC GGT ACT GCA CTC GTT GAA GAG AAC CTC CAT GCG CTC ATC AAC CCT 1119 He Gly Thr Ala Leu Val Glu Glu Asn Leu His Ala Leu He Asn Pro 330 335 340 345 GGC GCT CCG GGC GGC TCC GCT CCC GCA GAC GTT TCC CTC AAT CTT GCA 1167 Gly Ala Pro Gly Gly Ser Ala Pro Ala Asp Val Ser Leu Asn Leu Ala 350 355 360 ATT GGG CGC AGC ACA GTT GAT GGG ATT CTT AGG TTC ACA TTT AAT AAC 1215 He Gly Arg Ser Thr Val Asp Gly He Leu Arg Phe Thr Phe Asn Asn 365 370 375 ATC AAG TAC GAG GCT CCT TCG TTG CCC ACG CTC TTG AAG ATT TTG GCA 1263 He Lys Tyr Glu Ala Pro Ser Leu Pro Thr Leu Leu Lys He Leu Ala 380 385 390 AAC AAT GCG AGC AAT GAC GCC GAT TTC ACG CCA AAT GAG CAC ACT ATC 1311 Asn Asn Ala Ser Asn Asp Ala Asp Phe Thr Pro Asn Glu His Thr He 395 400 405 GTA TTG CCA CAC AAT AAA GTT ATC GAG CTC AAT ATC ACC GGA GGT GCA 1359 Val Leu Pro His Asn Lys Val He Glu Leu Asn He Thr Gly Gly Ala 410 415 420 425 GAC CAC CCT ATC CAT CTC CAC GGC CAT GTG TTT GAT ATC GTC AAA TCA 1407 Asp His Pro He His Leu His Gly His Val Phe Asp He Val Lys Ser 430 435 440 CTC GGT GGT ACC CCG AAC TAT GTC AAC CCG CCA CGC AGG GAC GTA GTT 1455 Leu Gly Gly Thr Pro Asn Tyr Val Asn Pro Pro Arg Arg Asp Val Val 445 450 455 CGT GTC GGA GGC ACC GGT GTG GTA CTC CGA TTC AAG ACC GAT AAC CCA 1503 Arg Val Gly Gly Thr Gly Val Val Leu Arg Phe Lys Thr Asp Asn Pro 460 465 470 GGC CCA TGG TTT GTT CAC TGC CAC ATT GAC TGG CAC TTG GAG GCT GGG 1551 Gly Pro Trp Phe Val His Cys His He Asp Trp His Leu Glu Ala Gly 475 480 485 CTC GCA CTT GTC TTT GCC GAG GCC CCC AGC CAG ATT CGC CAG GGT GTC 1599 Leu Ala Leu Val Phe Ala Glu Ala Pro Ser Gin He Arg Gin Gly Val 490 495 500 505 CAG TCG GTC CAG CCC AAC AAT GCC TGG AAC CAG CTC TGC CCC AAG TAC 1647 Gin Ser Val Gin Pro Asn Asn Ala Trp Asn Gin Leu Cys Pro Lys Tyr 510 515 520 GCG GCT CTT CCT CCC GAT TTG CAG T 1672 Ala Ala Leu Pro Pro Asp Leu Gin 525 (2) INFORMATION FOR SEQ ID NO:14: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 529 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:14: Met Leu Ser Ser He Thr Leu Leu Pro Leu Leu Ala Ala Val Ser Thr 1 5 10 15 Pro Ala Phe Ala Ala Val Arg Asn Tyr Lys Phe Asp He Lys Asn Val 20 25 30 Asn Val Ala Pro Asp Gly Phe Gin Arg Ser He Val Ser Val Asn Gly 35 40 45 Leu Val Pro Gly Thr Leu He Thr Ala Asn Lys Gly Asp Thr Leu Arg 50 55 60 He Asn Val Thr Asn Gin Leu Thr Asp Pro Ser Met Arg Arg Ala Thr 65 70 75 80 Thr He His Trp His Gly Leu Phe Gin Ala Thr Thr Ala Asp Glu Asp 85 90 95 Gly Pro Ala Phe Val Thr Gin Cys Pro He Ala Gin Asn Leu Ser Tyr 100 105 110 Thr Tyr Glu He Pro Leu Arg Gly Gin Thr Gly Thr Met Trp Tyr His 115 120 125 Ala His Leu Ala Ser Gin Tyr Val Asp Gly Leu Arg Gly Pro Leu Val 130 135 140 He Tyr Asp Pro Asn Asp Pro His Lys Ser Arg Tyr Asp Val Asp Asp 145 150 155 160 Ala Ser Thr Val Val Met Leu Glu Asp Trp Tyr His Thr Pro Ala Pro 165 170 175 Val Leu Glu Lys Gin Met Phe Ser Thr Asn Asn Thr Ala Leu Leu Ser 180 185 190 Pro Val Pro Asp Ser Gly Leu He Asn Gly Lys Gly Arg Tyr Val Gly 195 200 205 Gly Pro Ala Val Pro Arg Ser Val He Asn Val Lys Arg Gly Lys Arg 210 215 220 Tyr Arg Leu Arg Val He Asn Ala Ser Ala He Gly Ser Phe Thr Phe 225 230 235 240 Ser He Glu Gly His Ser Leu Thr Val He Glu Ala Asp Gly He Leu 245 250 255 His Gin Pro Leu Ala Val Asp Ser Phe Gin He Tyr Ala Gly Gin Arg 260 265 270 Tyr Ser Val He Val Glu Ala Asn Gin Thr Ala Ala Asn Tyr Trp He 275 280 285 Arg Ala Pro Met Thr Val Ala Gly Ala Gly Thr Asn Ala Asn Leu Asp 290 295 300 Pro Thr Asn Val Phe Ala Val Leu His Tyr Glu Gly Ala Pro Asn Ala 305 310 315 320 Glu Pro Thr Thr Glu Gin Gly Ser Ala He Gly Thr Ala Leu Val Glu 325 330 335 Glu Asn Leu His Ala Leu He Asn Pro Gly Ala Pro Gly Gly Ser Ala 340 345 350 Pro Ala Asp Val Ser Leu Asn Leu Ala He Gly Arg Ser Thr Val Asp 355 360 365 Gly He Leu Arg Phe Thr Phe Asn Asn He Lys Tyr Glu Ala Pro Ser 370 375 380 Leu Pro Thr Leu Leu Lys He Leu Ala Asn Asn Ala Ser Asn Asp Ala 385 390 395 400 Asp Phe Thr Pro Asn Glu His Thr He Val Leu Pro His Asn Lys Val 405 410 415 He Glu Leu Asn He Thr Gly Gly Ala Asp His Pro He His Leu His 420 425 430 Gly His Val Phe Asp He Val Lys Ser Leu Gly Gly Thr Pro Asn Tyr 435 440 445 Val Asn Pro Pro Arg Arg Asp Val Val Arg Val Gly Gly Thr Gly Val 450 455 460 Val Leu Arg Phe Lys Thr Asp Asn Pro Gly Pro Trp Phe Val His Cys 465 470 475 480 His He Asp Trp His Leu Glu Ala Gly Leu Ala Leu Val Phe Ala Glu 485 490 495 Ala Pro Ser Gin He Arg Gin Gly Val Gin Ser Val Gin Pro Asn Asn 500 505 510 Ala Trp Asn Gin Leu Cys Pro Lys Tyr Ala Ala Leu Pro Pro Asp Leu 515 520 525 Gin

Claims: What we claim is : 1. A nucleic acid fragment containing a nucleic acid sequence encoding a Rhizoctonia laccase which functions optimally at pH between about 6.0 and 8.5. 2. The fragment of Claim 1 which comprises a sequence encoding a Rhizoctonia solani laccase. 3. The fragment of Claim 1 which comprises a nucleic acid sequence encoding the amino acid sequence depicted in SEQ ID NO. 2. 4. The fragment of Claim 1 which comprises a nucleic acid sequence encoding the amino acid sequence depicted in SEQ ID NO. 4. 5. The fragment of Claim 1, which comprises a nucleic acid sequence encoding a protein containing one or more of the amino acid sequences depicted in SEQ. ID NOS. 5, 6, 7, 8, 9, 10, 11, or 12. 6. The fragment of Claim 1 which comprises a nucleic acid sequence encoding the amino acid sequence depicted in SEQ ID NO. 14. 7. The fragment of Claim 1, which comprises the nucleic acid sequence depicted in SEQ ID NO. 1. 8. The fragment of Claim 1, which comprises the nucleic acid sequence depicted in SEQ. ID. NO. 3. 9. The fragment of Claim 1, which comprises the nucleic acid sequence depicted in SEQ. ID. NO. 13. 10. The fragment of Claim 1, which comprises the nucleic acid sequence contained in NRRL B-21141. 11. The fragment of Claim 1, which comprises the nucleic acid sequence contained in NRRL B-21142. 12. The fragment of Claim 1, which comprises the nucleic acid sequence encoding the laccase produced by RS 22. 13. The fragment of Claim 1, which comprises the nucleic acid sequence contained in NRRL B-21156. 14. A substantially pure Rhizoctonia laccase enzyme which functions optimally at a pH between about 6.0-8.5. 15. The enzyme of Claim 14 which is a Rhizoctonia solani laccase. 16. The enzyme of Claim 14 which comprises the sequence depicted in SEQ ID NO. 2, or a sequence with at least 80% homology thereto. 17. The enzyme of Claim 14 which comprises the sequence depicted in SEQ ID NO 4, or a sequence with at least 80% homology thereto. 18. The enzyme of Claim 14 which comprises one or more of the peptide sequences depicted in SEQ ID NOS.5, 6, 7, 8, 9, 10, 11 or 12, or a sequence with at least 80% homology to one or more of these peptides. 19. The enzyme of Claim 14 which comprises the sequence depicted in SEQ ID NO 14, or a sequence with at least 80% homology thereto. 20. A recombinant vector comprising a nucleic acid fragment containing a nucleic acid sequence encoding a Rhizoctonia laccase which functions optimally at pH between about 6.0- 8.5. 21. The vector of Claim 20 in which the fragment is operably linked to a promoter sequence. 22. The vector of Claim 21 in which the promoter is a fungal or yeast promoter. 23. The vector of Claim 22 in which the promoter is the TAKA amylase promoter of Aspergillus oryzae. 24. The vector of Claim 22 in which the promoter is the glucoamylase (gluA) promoter of Aspergillus niger or Aspergillus awamsii . 25. The vector of Claim 21 which also comprises a selectable marker. 26. The vector of Claim 25 in which the selectable marker is the amdS marker of Aspergillus nidulans or Aspergillus oryzae. 27. The vector of Claim 25 in which the selectable marker is the pyrG marker of Aspergillus nidulans, Aspergillus niger, Aspergillus awamorii , or Aspergillus oryzae . 28. The vector of Claim 21 which comprises both the TAKA amylase promoter of Aspergillus oryzae and the amdS or pyrG marker of Aspergillus nidulans or Aspergillus oryzae. 29. A host cell comprising a heterologous nucleic acid fragment containing a nucleic acid sequence encoding a Rhizoctonia laccase which functions optimally at pH between about 6.0-8.5. 30. The host cell of Claim 28 which is a fungal cell. 31. The host cell of Claim 30 which is an Aspergillus cell. 32. The host cell of Claim 29 in which the fragment is integrated into the host cell genome. 33. The host cell of Claim 29 in which the fragment is contained on a vector. 34. The host cell of Claim 29 which comprises a fragment containing a sequence encoding the amino acid sequence depicted in SEQ ID NO. 2. 35. The host cell of Claim 29 which comprises a fragment containing a sequence encoding the amino acid sequence depicted in SEQ ID NO: 4. 36. The host cell of Claim 29 which comprises a fragment containing a sequence encoding the amino acid sequence depicted in SEQ ID NO: 14. 37. The host cell of Claim 29 which comprises a fragment containing a sequence encoding one or more of the amino acid sequences depicted in SEQ ID NOS.: 5, 6, 7, 8, 9, 10, 11, or 12. 38. A method for obtaining a laccase enzyme which functions optimally at a pH between about 6.0-8.5 which comprises culturing a host cell comprising a nucleic acid fragment containing a nucleic acid sequence encoding a Rhizoctonia laccase enzyme which functions optimally at a pH between about 6.0-8.5, under conditions conducive to expression of the enzyme, and recovering the enzyme from the culture. 39. A method for polymerizing a lignin or lignosulfate substrate in solution which comprises contacting the substrate with a Rhizoctonia laccase which functions optimally at a pH between about 6.0-8.5. 40. A method for in situ depolymerization in Kraft pulp which comprises contacting the pulp with a Rhizoctonia laccase which functions optimally at a pH between about 6.0- 8.5. 41. A method for oxidizing dyes which comprises contacting the dye with a Rhizoctonia laccase which functions optimally at a pH between about 6.0-8.5. 42. A method of polymerizing a phenolic compounds which comprises contacting the phenolic compound with a Rhizoctonia laccase which functions optimally at a pH between about 6.0-8.5.

Inventors: CHRISTENSEN BJOERN EGGERT, SCHNEIDER PALLE, WAHLEITHNER JILL ANGELA, CHRISTENSEN, BJOERN, EGGERT, SCHNEIDER, PALLE, WAHLEITHNER, JILL, ANGELA
Applicants: NOVO NORDISK BIOTECH INC, NOVONORDISK AS, NOVO NORDISK A/S, NOVO NORDISK BIOTECH, INC.
Application year: 1994
Main classification: C12N15
IPC codes: C07H21, C07K14, C08H5, C11D3, C12N1, C12N9, C12N15, C12R1, D06P1, D06P5, D21C9